Milan Hora (@milanhoraplzen) 's Twitter Profile
Milan Hora

@milanhoraplzen

University Hospital @FNPlzen, CZ, head of @Urology_Plzen, @CUS_CLS_JEP - vice-chairman, @Czechurology - editor-in-chief, RCC guidelines panel @Uroweb - member

ID: 2844648361

linkhttp://urol.fnplzen.cz/ calendar_today07-10-2014 20:16:19

1,1K Tweet

1,1K Takipçi

675 Takip Edilen

Milan Hora (@milanhoraplzen) 's Twitter Profile Photo
Milan Hora
@milanhoraplzen

5 months ago

Adjuvant Pembrolizumab vs Observation in Muscle-Invasive Urothelial Carcinoma after radical surgery, disease-free survival 29.6 vs 14.2 months, hazard ratio for disease progression / death 0.73; AMBASSADOR trial, N Engl J Med. 2025 Jan 2;392(1):45-55 pubmed.ncbi.nlm.nih.gov/39282902/

Adjuvant Pembrolizumab vs Observation in Muscle-Invasive Urothelial Carcinoma after radical surgery, disease-free survival 29.6 vs 14.2 months, hazard ratio for disease progression / death 0.73; AMBASSADOR trial, N Engl J Med. 2025 Jan 2;392(1):45-55 pubmed.ncbi.nlm.nih.gov/39282902/